Anti-IBP4/ IGFBP4/ BP-4 functional antibody

Anti-IBP4/ IGFBP4/ BP-4 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IGFBP4/IGFBP4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0986-Ab-1/ GM-Tg-hg-SE0986-Ab-2Anti-Human IGFBP4 monoclonal antibodyHuman
GM-Tg-rg-SE0986-Ab-1/ GM-Tg-rg-SE0986-Ab-2Anti-Rat IGFBP4 monoclonal antibodyRat
GM-Tg-mg-SE0986-Ab-1/ GM-Tg-mg-SE0986-Ab-2Anti-Mouse IGFBP4 monoclonal antibodyMouse
GM-Tg-cynog-SE0986-Ab-1/ GM-Tg-cynog-SE0986-Ab-2Anti-Cynomolgus/ Rhesus macaque IGFBP4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0986-Ab-1/ GM-Tg-felg-SE0986-Ab-2Anti-Feline IGFBP4 monoclonal antibodyFeline
GM-Tg-cang-SE0986-Ab-1/ GM-Tg-cang-SE0986-Ab-2Anti-Canine IGFBP4 monoclonal antibodyCanine
GM-Tg-bovg-SE0986-Ab-1/ GM-Tg-bovg-SE0986-Ab-2Anti-Bovine IGFBP4 monoclonal antibodyBovine
GM-Tg-equg-SE0986-Ab-1/ GM-Tg-equg-SE0986-Ab-2Anti-Equine IGFBP4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0986-Ab-1/ GM-Tg-hg-SE0986-Ab-2; GM-Tg-rg-SE0986-Ab-1/ GM-Tg-rg-SE0986-Ab-2;
GM-Tg-mg-SE0986-Ab-1/ GM-Tg-mg-SE0986-Ab-2; GM-Tg-cynog-SE0986-Ab-1/ GM-Tg-cynog-SE0986-Ab-2;
GM-Tg-felg-SE0986-Ab-1/ GM-Tg-felg-SE0986-Ab-2; GM-Tg-cang-SE0986-Ab-1/ GM-Tg-cang-SE0986-Ab-2;
GM-Tg-bovg-SE0986-Ab-1/ GM-Tg-bovg-SE0986-Ab-2; GM-Tg-equg-SE0986-Ab-1/ GM-Tg-equg-SE0986-Ab-2
Products NameAnti-IGFBP4 monoclonal antibody
Formatmab
Target NameIGFBP4
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IGFBP4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0986-Ag-1Recombinant multi-species IBP4/ IGFBP4/ BP-4 protein
    CytokineGM-Tg-g-SE0986-Ag-1insulin-like growth factor binding protein 4 (IGFBP4) protein
    ORF Viral VectorvGMLP003022human IGFBP4 Lentivirus particle
    ORF Viral VectorpGMLP003022human IGFBP4 Lentivirus plasmid
    ORF Viral VectorpGMLPm002827mouse Igfbp4 Lentivirus plasmid
    ORF Viral VectorvGMLPm002827mouse Igfbp4 Lentivirus particle


    Target information

    Target IDGM-SE0986
    Target NameIGFBP4
    Gene ID3487,16010,360622,700963,608158,101082792,282262,100034062
    Gene Symbol and SynonymsBP-4,Deb2,HT29-IGFBP,IBP-4,IBP4,IGF-BP4,IGFBP-4,IGFBP4
    Uniprot AccessionP22692,P21744,Q05716
    Uniprot Entry NameIBP4_HUMAN,IBP4_RAT,IBP4_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseasePancreas Cancer, Dent disease
    Gene EnsemblENSG00000141753
    Target ClassificationN/A

    The target: IGFBP4, gene name: IGFBP4, also named as BP-4, HT29-IGFBP, IBP4, IGFBP-4. This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma in both glycosylated and non-glycosylated forms. Binding of this protein prolongs the half-life of the IGFs and alters their interaction with cell surface receptors. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.